Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K201 cream versus Jellin Basis Creme in atopic eczema
2008-005890-37Phase 2Completed
- Sponsor
- Moberg Pharma AB
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of K201 in atopic dermatitis (AD) (2 arms), sponsored by Moberg Pharma AB. Primary endpoints: Barrier impairment, Clinical skin condition and 1 more. Started Oct 2008; status: completed.
02
Drugs
K201
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2008-005890-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005890-37.